COVID-19 Portfolio
We help you avoid fraudulent & non-certified testing
We’ve done the work for you.
Our rigorous vetting process is conducted by industry professionals with an accomplished history of providing guidance and launching numerous medical products into the U.S. Market.
We continue to challenge the market to provide products that meet or exceed our industry leading standards.
Value Based – Turnkey – Powered
- Quality
- Sensitivity & Specificity
- Production Capabilities
- Raw Goods Quality & Availability
- Order Volume
- HC CLIA
- Country of Origin
Testing Authentication
With Personal Verification
US Med Test Registry Portfolio, our anti-counterfeit product verification assures test authenticity and validity. This eliminates the worry of using counterfeit/uncertified test kits.
Real-time reporting of test results includes age, gender, and geolocation (GPS coordinates) accelerates and enhances the health system response.
The analytics dashboard shows infection rates of specific areas, IgM and IgG antibody testing, and assists public health and provides instant response to the pandemic.
Choose From Our Testing Solutions
Option 1 | RDT – Serological
Name:Reserved* |
Type:Rapid Diagnostic Test (RDT) |
Personal Verification:Rymedi |
Production Capabilities:1 Million / week |
Country of Origin:China |
510K:No |
Sensitivity:95.7% |
EUA:Yes |
Specificity:99.0% |
High Complexity CLIA Lab:Yes |
Option 2 | RDT – Serological
Name:Reserved* |
Type:Rapid Diagnostic Test (RDT) |
Personal Verification:Rymedi |
Production Capabilities:1 Million / week |
Country of Origin:China |
510K:No |
Sensitivity:99.0% |
EUA:Yes |
Specificity:99.0% |
High Complexity CLIA Lab:Yes |
Option 3 | Rapid PCR
Name:Reserved* |
Type:Rapid PCR |
Personal Verification:Rymedi |
Production Capabilities:250k / week |
Country of Origin:China |
510K:No |
Sensitivity:Result > 90% |
EUA:Yes |
Specificity:Result > 90% |
High Complexity CLIA Lab:Yes |
Option 4 | RDT – Serological
Name:Reserved* |
Type:Rapid Diagnostic Test (RDT) |
Personal Verification:Rymedi |
Production Capabilities:1 Million / week |
Country of Origin:USA |
510K:No |
Sensitivity:97.0% |
EUA:No |
Specificity:99.0% |
High Complexity CLIA Lab:Yes |
Option 5 | Serological / E.L.I.S.A.
Name:Reserved* |
Type:Serological / E.L.I.S.A. |
Personal Verification:Rymedi |
Production Capabilities:500k / week |
Country of Origin:USA |
510K:No |
Sensitivity:Result > 90% |
EUA:No |
Specificity:Result > 90% |
High Complexity CLIA Lab:Yes |
Option 6 | RDT – Serological
Name:Reserved* |
Type:Rapid Diagnostic Test (RDT) |
Personal Verification:Rymedi |
Production Capabilities:500k / week |
Country of Origin:USA |
510K:No |
Sensitivity:90.4% |
EUA:No |
Specificity:98.3% |
High Complexity CLIA Lab:Yes |
State Agencies
We are diligently working with other states and other countries that need to access rapid diagnostic testing with US Med Test technology.
Hospitals & Clinics
American Businesses
Choose From Our PPE Solutions
Nitrite Gloves
Face Shields
Surgical Masks Type I & II
IR Thermometer
Mobile ICU Platform
Hand Sanitizer 70% & 80%
BEMER

The Team at US Med Test delivers confidence in the environment and interactions that are within your control. We utilize cutting edge technology including non-invasive testing to deliver immediate results. Our testing programs are administered by skilled, verified health care professionals that coordinate with our High Complexity CLIA Lab network to deliver consistent, affordable results.
All US Med Test programs and testing meet or exceed the standards of federal reporting to help create actionable efforts in pro-active prevention and containment. Our software partners use dual encryption and blockchain technology to identify every patient and ensure privacy rights and ensure HIPAA compliance.
Contact
Get In Touch
(800) 424-4339
info@USMedTest.com
Hours:
If you need our help, we are here for you. 24/7 - 365